Primary Hyperparathyroidism May Not Be Associated With Adverse Clinical and Functional Outcomes After Total Hip Arthroplasty

INTRODUCTION: Primary hyperparathyroidism (PHPT) can result in reduced bone mineral density and increased fracture risk. Total hip arthroplasty (THA) is commonly performed for end-stage osteoarthritis, but the metabolic effects of PHPT on perioperative outcomes are unclear. We evaluated PHPT's association with clinical and functional outcomes following THA. MATERIALS AND METHODS: This was a single-center retrospective study of patients who underwent primary THA from January 2016 to December 2024. Patients who underwent biochemical evaluation for parathyroid disease (PHPT versus controls) were included. All patients completed the Hip Disability and Osteoarthritis Outcome Score for Joint Replacement (HOOS-JR), a validated instrument assessing THA-related hip function, at baseline and one year after THA. Postoperative improvements in HOOS-JR scores were compared between groups. Multivariable regression was used to identify factors predicting failure in postoperative improvement. RESULTS: Of 13,487 patients who underwent THA, 519 (3.8%) underwent biochemical evaluation: 155 with PHPT (15.5% classic, 69.7% normocalcemic, 14.8% normohormonal) and 364 controls. The PHPT cohort had slightly lower baseline [39.9 (IQR: 29.0-47.5) versus 43.3 (IQR: 32.7-53.0), P = 0.018] and 1-y [76.8 (IQR: 64.7-92.3) versus 85.4 (IQR: 70.4-100), P = 0.031] HOOS-JR scores compared to controls. Both groups observed significant improvement (95% versus 92%, P = 0.702), while reported rates of satisfaction tended to be worse with PHPT (49% versus 62%, P = 0.053), one year after surgery. PHPT was not independently associated with poorer patient-reported outcomes postoperatively (OR: 0.71, 95% CI: 0.22-2.28, P = 0.568). CONCLUSIONS: PHPT was not an independent predictor of decreased clinical or functional outcomes following THA. These findings suggest that patients diagnosed with PHPT may safely pursue THA and expect meaningful improvement in symptoms.

Authors

Institutions

Publication Details

Journal
Journal of Surgical Research
Published
2026-11-16
DOI
https://doi.org/10.1016/j.jss.2026.10.050
Primary Topic
Orthopaedic implants and arthroplasty
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Primary Hyperparathyroidism May Not Be Associated With Adverse Clinical and Functional Outcomes After Total Hip Arthroplasty

Matthew E. Deren, Chao Zhang, Gustavo Romero‐Velez, Justin S. Bauzon et al.
1 links
Journal of Surgical Research
Orthopaedic implants and arthroplasty
article

Primary Hyperparathyroidism May Not Be Associated With Adverse Clinical and Functional Outcomes After Total Hip Arthroplasty

Matthew E. Deren, Chao Zhang, Gustavo Romero‐Velez, Justin S. Bauzon, Lakshmi Spandana Gudapati, Judy Jin, Nicolas S. Piuzzi, Jacob Moore, Shujaa T. Khan
article en

Abstract

INTRODUCTION: Primary hyperparathyroidism (PHPT) can result in reduced bone mineral density and increased fracture risk. Total hip arthroplasty (THA) is commonly performed for end-stage osteoarthritis, but the metabolic effects of PHPT on perioperative outcomes are unclear. We evaluated PHPT's association with clinical and functional outcomes following THA. MATERIALS AND METHODS: This was a single-center retrospective study of patients who underwent primary THA from January 2016 to December 2024. Patients who underwent biochemical evaluation for parathyroid disease (PHPT versus controls) were included. All patients completed the Hip Disability and Osteoarthritis Outcome Score for Joint Replacement (HOOS-JR), a validated instrument assessing THA-related hip function, at baseline and one year after THA. Postoperative improvements in HOOS-JR scores were compared between groups. Multivariable regression was used to identify factors predicting failure in postoperative improvement. RESULTS: Of 13,487 patients who underwent THA, 519 (3.8%) underwent biochemical evaluation: 155 with PHPT (15.5% classic, 69.7% normocalcemic, 14.8% normohormonal) and 364 controls. The PHPT cohort had slightly lower baseline [39.9 (IQR: 29.0-47.5) versus 43.3 (IQR: 32.7-53.0), P = 0.018] and 1-y [76.8 (IQR: 64.7-92.3) versus 85.4 (IQR: 70.4-100), P = 0.031] HOOS-JR scores compared to controls. Both groups observed significant improvement (95% versus 92%, P = 0.702), while reported rates of satisfaction tended to be worse with PHPT (49% versus 62%, P = 0.053), one year after surgery. PHPT was not independently associated with poorer patient-reported outcomes postoperatively (OR: 0.71, 95% CI: 0.22-2.28, P = 0.568). CONCLUSIONS: PHPT was not an independent predictor of decreased clinical or functional outcomes following THA. These findings suggest that patients diagnosed with PHPT may safely pursue THA and expect meaningful improvement in symptoms.

Journal of Surgical ResearchVol. 328
Cleveland Clinic (US), Cleveland Clinic Lerner College of Medicine (US), Case Western Reserve University (US)
Good health and well-being
Orthopaedic implants and arthroplasty
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon